Hannah Wardill’s fight against cancer

Supportive Oncology Research Group Founder Hannah Wardill is dedicated to eradicating the physical, psychological and financial burden of cancer and its treatment. Last week, she was named winner of the Social Impact award at InDaily’s 40 Under 40 for 2020.

Oct 29, 2020, updated Oct 29, 2020
Hannah Wardill was named winner of the Social Impact award by Community Corporate at InDaily’s 40 Under 40 for 2020. Image: Morgan Sette.

Hannah Wardill was named winner of the Social Impact award by Community Corporate at InDaily’s 40 Under 40 for 2020. Image: Morgan Sette.

Wardill took out the Social Impact Award, presented by Community Corporate, for her work advocating for cancer survivors while trying to find ways to improve the lives of people with cancer.

According to the Cancer Council, an estimated 150,000 Australians were diagnosed with the disease in 2020.

It’s the nation’s leading killer but about seven in every 10 Australians survive for at least five years after their diagnosis.

Wardill’s ambitious but, ultimately, simple goal is to stop the burden of cancer diagnosis and its long-term emotional and economic impacts on survivors through innovative and supportive care solutions tailored to meet the unique needs of each patient.

To achieve her mission, the young South Australian has established the independent multidisciplinary research group SORG (Supportive Oncology Research Group).

The organisation aims to target consumer engagement and develop innovative scientific approaches to cancer treatment and recovery.

She said while the group was still in its infancy she had secured close to $1 million in competitive grant funding to support the development of innovative supportive care solutions designed for patient’s unique needs.

Wardill said the challenges of pursuing a career in medical research were many and diverse but reduced government spending on science and research had exacerbated the issue.

“Independent medical researchers, unlike the past, are now entirely dependent on grant funding which is largely administered by the National Health and Medical Research Council (NHMRC),” Wardill said.

InDaily in your inbox. The best local news every workday at lunch time.
By signing up, you agree to our User Agreement andPrivacy Policy & Cookie Statement. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

“However, since 2010, the success rates for NHMRC funding has steadily declined while the number of high-quality applications has continued to increase.

“Early career researchers are less likely to be funded, especially if they are female, with more and more disenchanted ECRs leaving academia citing job insecurity as the major cause.

“But I am committed to carving out a researcher career simply because I believe my area of research is completely under-valued, and the needs of people with cancer remain poorly prioritised.”

Since starting her career in supportive oncology, Wardill said she’d published more than 40 peer-reviewed scientific publications, developed and disseminated evidence-based clinical practice guidelines, which have been translated into nine languages, and published a book chapter.

She has won a slew of awards for her work, including the South Australian Young Achiever and a NHMRC CJ Martin Biomedical training fellowship in the Netherlands.

She returned to Australia to establish SORG.

The third annual award winners were announced on Thursday, 22 October. See the full list here.

Local News Matters
Copyright © 2024 InDaily.
All rights reserved.